Cargando…
Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome
BACKGROUND: The clustering of cardiovascular risk factors is termed the metabolic syndrome (MS), which strongly predicts the risk of diabetes and cardiovascular disease (CVD). Adipokines may contribute to the development of obesity and insulin resistance and may be a causal link between MS, diabetes...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263179/ https://www.ncbi.nlm.nih.gov/pubmed/22276262 http://dx.doi.org/10.4103/2230-8210.91206 |